Skip to main content
SpringerLink
Log in

Adalimumab/efalizumab/infliximab

Psoriasis: 5 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Inmaculada MF, Rocío BB, Sergio GP.Psoriasis induced by biological therapies. 2008 Annual European Congress of Rheumatology: abstr. AB0296, 11 Jun 2008. Available from: URL: http://www.eular.org - Spain

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adalimumab/efalizumab/infliximab. React. Wkly. 1210, 5 (2008). https://doi.org/10.2165/00128415-200812100-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812100-00013

Keywords

Search

Navigation